Literature DB >> 10779553

Gain of imprinting at chromosome 11p15: A pathogenetic mechanism identified in human hepatocarcinomas.

C Schwienbacher1, L Gramantieri, R Scelfo, A Veronese, G A Calin, L Bolondi, C M Croce, G Barbanti-Brodano, M Negrini.   

Abstract

Genomic imprinting is a reversible condition that causes parental-specific silencing of maternally or paternally inherited genes. Analysis of DNA and RNA from 52 human hepatocarcinoma samples revealed abnormal imprinting of genes located at chromosome 11p15 in 51% of 37 informative samples. The most frequently detected abnormality was gain of imprinting, which led to loss of expression of genes present on the maternal chromosome. As compared with matched normal liver tissue, hepatocellular carcinomas showed extinction or significant reduction of expression of one of the alleles of the CDKN1C, SLC22A1L, and IGF2 genes. Loss of maternal-specific methylation at the KvDMR1 locus in hepatocarcinoma correlated with abnormal expression of CDKN1C and IGF2, suggesting a function for KvDMR1 as a long-range imprinting center active in adult tissues. These results point to the role of epigenetic mechanisms leading to loss of expression of imprinted genes at chromosome region 11p15 in human tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779553      PMCID: PMC25848          DOI: 10.1073/pnas.090087497

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19-independent pathway.

Authors:  K W Brown; A J Villar; W Bickmore; J Clayton-Smith; D Catchpoole; E R Maher; W Reik
Journal:  Hum Mol Genet       Date:  1996-12       Impact factor: 6.150

2.  Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome.

Authors:  P Zhang; N J Liégeois; C Wong; M Finegold; H Hou; J C Thompson; A Silverman; J W Harper; R A DePinho; S J Elledge
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

3.  Human KVLQT1 gene shows tissue-specific imprinting and encompasses Beckwith-Wiedemann syndrome chromosomal rearrangements.

Authors:  M P Lee; R J Hu; L A Johnson; A P Feinberg
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

Review 4.  Imprinting in clusters: lessons from Beckwith-Wiedemann syndrome.

Authors:  W Reik; E R Maher
Journal:  Trends Genet       Date:  1997-08       Impact factor: 11.639

5.  An imprinted gene p57KIP2 is mutated in Beckwith-Wiedemann syndrome.

Authors:  I Hatada; H Ohashi; Y Fukushima; Y Kaneko; M Inoue; Y Komoto; A Okada; S Ohishi; A Nabetani; H Morisaki; M Nakayama; N Niikawa; T Mukai
Journal:  Nat Genet       Date:  1996-10       Impact factor: 38.330

6.  Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution.

Authors:  M H Lee; I Reynisdóttir; J Massagué
Journal:  Genes Dev       Date:  1995-03-15       Impact factor: 11.361

7.  Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.

Authors:  M Negrini; D Rasio; G M Hampton; S Sabbioni; S Rattan; S L Carter; A L Rosenberg; G F Schwartz; Y Shiloh; W K Cavenee
Journal:  Cancer Res       Date:  1995-07-15       Impact factor: 12.701

8.  Inherited microdeletions in the Angelman and Prader-Willi syndromes define an imprinting centre on human chromosome 15.

Authors:  K Buiting; S Saitoh; S Gross; B Dittrich; S Schwartz; R D Nicholls; B Horsthemke
Journal:  Nat Genet       Date:  1995-04       Impact factor: 38.330

9.  Somatic mutation of TSSC5, a novel imprinted gene from human chromosome 11p15.5.

Authors:  M P Lee; C Reeves; A Schmitt; K Su; T D Connors; R J Hu; S Brandenburg; M J Lee; G Miller; A P Feinberg
Journal:  Cancer Res       Date:  1998-09-15       Impact factor: 12.701

10.  Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15.

Authors:  S Matsuoka; J S Thompson; M C Edwards; J M Bartletta; P Grundy; L M Kalikin; J W Harper; S J Elledge; A P Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

View more
  22 in total

1.  Cloning, expression and localization of human BM88 shows that it maps to chromosome 11p15.5, a region implicated in Beckwith-Wiedemann syndrome and tumorigenesis.

Authors:  M Gaitanou; P Buanne; C Pappa; N Georgopoulou; A Mamalaki; F Tirone; R Matsas
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

Review 2.  Specific changes in the expression of imprinted genes in prostate cancer--implications for cancer progression and epigenetic regulation.

Authors:  Teodora Ribarska; Klaus-Marius Bastian; Annemarie Koch; Wolfgang A Schulz
Journal:  Asian J Androl       Date:  2012-02-27       Impact factor: 3.285

3.  An information theoretic method to identify combinations of genomic alterations that promote glioblastoma.

Authors:  Rachel D Melamed; Jiguang Wang; Antonio Iavarone; Raul Rabadan
Journal:  J Mol Cell Biol       Date:  2015-05-04       Impact factor: 6.216

4.  Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105.

Authors:  H Y Yamada; G J Gorbsky
Journal:  Oncogene       Date:  2006-03-02       Impact factor: 9.867

5.  Development of targeted therapy for a broad spectrum of solid tumors mediated by a double promoter plasmid expressing diphtheria toxin under the control of IGF2-P4 and IGF2-P3 regulatory sequences.

Authors:  Doron Amit; Sagi Tamir; Abraham Hochberg
Journal:  Int J Clin Exp Med       Date:  2013-01-26

6.  Alternative mechanisms associated with silencing of CDKN1C in Beckwith-Wiedemann syndrome.

Authors:  N Diaz-Meyer; Y Yang; S N Sait; E R Maher; M J Higgins
Journal:  J Med Genet       Date:  2005-08       Impact factor: 6.318

7.  DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.

Authors:  Muhammad A Alvi; Xinxue Liu; Maria O'Donovan; Richard Newton; Lorenz Wernisch; Nicholas B Shannon; Kareem Shariff; Massimiliano di Pietro; Jacques J G H M Bergman; Krish Ragunath; Rebecca C Fitzgerald
Journal:  Clin Cancer Res       Date:  2012-12-14       Impact factor: 12.531

8.  Impaired expression of an organic cation transporter, IMPT1, in a knockout mouse model for kidney stone disease.

Authors:  Eleni G Tzortzaki; Min Yang; Dayna Glass; Li Deng; Andrew P Evan; Sharon B Bledsoe; Peter J Stambrook; Amrik Sahota; Jay A Tischfield
Journal:  Urol Res       Date:  2003-07-11

9.  Suggestive evidence for chromosomal localization of non-coding RNA from imprinted LIT1.

Authors:  Kazuhiro Murakami; Mitsuo Oshimura; Hiroyuki Kugoh
Journal:  J Hum Genet       Date:  2007-10-05       Impact factor: 3.172

Review 10.  MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches.

Authors:  E Callegari; L Gramantieri; M Domenicali; L D'Abundo; S Sabbioni; M Negrini
Journal:  Cell Death Differ       Date:  2014-09-05       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.